AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
2.670
-0.040 (-1.48%)
At close: Nov 20, 2024, 4:00 PM
2.630
-0.040 (-1.50%)
Pre-market: Nov 21, 2024, 4:59 AM EST

AbCellera Biologics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
Net Income
-175.8-146.4158.52153.46118.92-2.21
Upgrade
Depreciation & Amortization
92.2130.8924.717.255.271.85
Upgrade
Asset Writedown & Restructuring Costs
--8.4---
Upgrade
Stock-Based Compensation
68.864.1849.4830.658.40.89
Upgrade
Other Operating Activities
-66.05-5.786.431.556.810.19
Upgrade
Change in Accounts Receivable
-64.7-36.66106.4622.48-203.02-1.8
Upgrade
Change in Accounts Payable
-9.23-15.1-2.09-3.246.60.15
Upgrade
Change in Unearned Revenue
19.625.5515.4539.3415.05-0.01
Upgrade
Change in Income Taxes
-6.9330.46-88.61-13.5336.41-
Upgrade
Change in Other Net Operating Assets
21.928.98-1.38-3.3828.263.63
Upgrade
Operating Cash Flow
-120.17-43.88277.36244.5822.692.69
Upgrade
Operating Cash Flow Growth
--13.40%977.94%742.24%-24.43%
Upgrade
Capital Expenditures
-77.2-76.95-70.66-58.45-9.67-4
Upgrade
Cash Acquisitions
----11.46-87.64-
Upgrade
Sale (Purchase) of Intangibles
-0.56-0.56-2--5-
Upgrade
Investment in Securities
99.7-168.91-296.4-294.96-17.46-
Upgrade
Other Investing Activities
39.4425.3116.4332.62--1.78
Upgrade
Investing Cash Flow
61.38-221.11-352.63-332.25-119.78-5.78
Upgrade
Short-Term Debt Issued
-----0.39
Upgrade
Long-Term Debt Issued
-11.592.765.4989.990.19
Upgrade
Total Debt Issued
12.6311.592.765.4989.990.58
Upgrade
Long-Term Debt Repaid
-----19.94-0.4
Upgrade
Total Debt Repaid
-----19.94-0.4
Upgrade
Net Debt Issued (Repaid)
12.6311.592.765.4970.050.18
Upgrade
Issuance of Common Stock
0.5---539.330.03
Upgrade
Other Financing Activities
-0.74-1.23-4.38-9.37-0.39-0.01
Upgrade
Financing Cash Flow
12.3910.36-1.63-3.89683.650.2
Upgrade
Foreign Exchange Rate Adjustments
0.610.59-9.6-1.43--
Upgrade
Net Cash Flow
-45.78-254.04-86.49-92.97586.56-2.89
Upgrade
Free Cash Flow
-197.36-120.82206.7186.1313.02-1.3
Upgrade
Free Cash Flow Growth
--11.05%1329.91%--
Upgrade
Free Cash Flow Margin
-598.76%-317.75%42.58%49.61%5.58%-11.22%
Upgrade
Free Cash Flow Per Share
-0.67-0.420.660.580.05-0.01
Upgrade
Levered Free Cash Flow
-105.58-102.96205.62143.8-24.06-3.23
Upgrade
Unlevered Free Cash Flow
-105.58-102.96205.62143.8-19.8-3.1
Upgrade
Change in Net Working Capital
-3.71-27.72-63.53-26.6116.32-0.74
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.